- Report
- April 2026
- 128 Pages
Global
From €3500EUR$4,079USD£3,080GBP
- Report
- February 2026
- 187 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- January 2026
- 200 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- November 2025
- 150 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- April 2026
- 75 Pages
United States
From €4366EUR$4,750USD£3,712GBP
- Report
- December 2025
- 150 Pages
United States
From €4458EUR$4,850USD£3,790GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4137EUR$4,500USD£3,517GBP
- Report
- October 2025
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- April 2026
- 80 Pages
Germany
From €4366EUR$4,750USD£3,712GBP
- Report
- April 2026
- 68 Pages
Brazil
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 110 Pages
United Kingdom
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 90 Pages
Chile
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 76 Pages
India
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 68 Pages
Japan
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 80 Pages
Italy
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 72 Pages
Sweden
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 85 Pages
China
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 68 Pages
Canada
From €4366EUR$4,750USD£3,712GBP
- Report
- April 2026
- 81 Pages
Saudi Arabia
From €4366EUR$4,750USD£3,712GBP
- Report
- April 2026
- 100 Pages
Spain
From €4366EUR$4,750USD£3,712GBP

The Bioprosthetic Valve market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to replace or repair a patient's heart valve. These valves are made from animal tissue, such as porcine or bovine, and are designed to mimic the natural functioning of the human heart valve. Bioprosthetic valves are used to treat a variety of conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation. They are also used in combination with other treatments, such as coronary artery bypass grafting.
Bioprosthetic valves are becoming increasingly popular due to their durability and low risk of complications. They are also cost-effective and require less maintenance than mechanical valves.
Some of the major companies in the Bioprosthetic Valve market include Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, and Sorin Group. Show Less Read more